140 related articles for article (PubMed ID: 21572399)
1. Tubal metaplasia of the endometrium with cytologic atypia: analysis of p53, Ki-67, TERT, and long-term follow-up.
Simon RA; Peng SL; Liu F; Quddus MR; Zhang C; Steinhoff MM; Lawrence WD; Sung CJ
Mod Pathol; 2011 Sep; 24(9):1254-61. PubMed ID: 21572399
[TBL] [Abstract][Full Text] [Related]
2. p53 immunoreactivity in endometrial metaplasia with dysfunctional uterine bleeding.
Quddus MR; Sung CJ; Zheng W; Lauchlan SC
Histopathology; 1999 Jul; 35(1):44-9. PubMed ID: 10383713
[TBL] [Abstract][Full Text] [Related]
3. The immunohistochemical profile of atypical eosinophilic syncytial changes vs serous carcinoma.
Haley SL; Malhotra RK; Qiu S; Eltorky ME
Ann Diagn Pathol; 2011 Dec; 15(6):402-6. PubMed ID: 21855381
[TBL] [Abstract][Full Text] [Related]
4. Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression.
Lax SF; Pizer ES; Ronnett BM; Kurman RJ
Hum Pathol; 1998 Jun; 29(6):551-8. PubMed ID: 9635673
[TBL] [Abstract][Full Text] [Related]
5. Papillary proliferation of the endometrium: a clinicopathologic study of 59 cases of simple and complex papillae without cytologic atypia.
Ip PP; Irving JA; McCluggage WG; Clement PB; Young RH
Am J Surg Pathol; 2013 Feb; 37(2):167-77. PubMed ID: 23211295
[TBL] [Abstract][Full Text] [Related]
6. Correlation of proliferation indices, apoptosis, and related oncogene expression (bcl-2 and c-erbB-2) and p53 in proliferative, hyperplastic, and malignant endometrium.
Ioffe OB; Papadimitriou JC; Drachenberg CB
Hum Pathol; 1998 Oct; 29(10):1150-9. PubMed ID: 9781657
[TBL] [Abstract][Full Text] [Related]
7. Endometrial glandular dysplasia: a newly defined precursor lesion of uterine papillary serous carcinoma. Part I: morphologic features.
Zheng W; Liang SX; Yu H; Rutherford T; Chambers SK; Schwartz PE
Int J Surg Pathol; 2004 Jul; 12(3):207-23. PubMed ID: 15306933
[TBL] [Abstract][Full Text] [Related]
8. Could Obesity be a Triggering Factor for Endometrial Tubal Metaplasia to be a Precancerous Lesion?
El-Saka AM; Zamzam YA; Zamzam YA; El-Dorf A
J Obes; 2020; 2020():2825905. PubMed ID: 32300484
[TBL] [Abstract][Full Text] [Related]
9. Significantly decreased P27 expression in endometrial carcinoma compared to complex hyperplasia with atypia (correlation with p53 expression).
Ozkara SK; Corakci A
Pathol Oncol Res; 2004; 10(2):89-97. PubMed ID: 15188025
[TBL] [Abstract][Full Text] [Related]
10. Papillary syncytial metaplasia associated with endometrial breakdown exhibits an immunophenotype that overlaps with uterine serous carcinoma.
McCluggage WG; McBride HA
Int J Gynecol Pathol; 2012 May; 31(3):206-10. PubMed ID: 22498936
[TBL] [Abstract][Full Text] [Related]
11. Expression of immunoreactivity and genetic mutation in eosinophilic and ciliated metaplastic changes of endometrial glandular and stromal breakdown: cytodiagnostic implications.
Shimizu K; Norimatsu Y; Kobayashi TK; Sakurai M; Ogura S; Yoshizawa A; Miyamoto T; Miyake Y; Aratake Y; Sakaguchi T; Ohno E
Ann Diagn Pathol; 2009 Apr; 13(2):89-95. PubMed ID: 19302956
[TBL] [Abstract][Full Text] [Related]
12. Nongynecologic metastases to fallopian tube mucosa: a potential mimic of tubal high-grade serous carcinoma and benign tubal mucinous metaplasia or nonmucinous hyperplasia.
Rabban JT; Vohra P; Zaloudek CJ
Am J Surg Pathol; 2015 Jan; 39(1):35-51. PubMed ID: 25025442
[TBL] [Abstract][Full Text] [Related]
13. Utility of Ki-67, p53, Bcl-2, and Cox-2 biomarkers for low-grade endometrial cancer and disordered proliferative/benign hyperplastic endometrium by imprint cytology.
Apostolou G; Apostolou N; Biteli M; Kavantzas N; Patsouris E; Athanassiadou P
Diagn Cytopathol; 2014 Feb; 42(2):134-42. PubMed ID: 23729350
[TBL] [Abstract][Full Text] [Related]
14. Atypical nephrogenic metaplasia of the urinary tract: a precursor lesion?
Cheng L; Cheville JC; Sebo TJ; Eble JN; Bostwick DG
Cancer; 2000 Feb; 88(4):853-61. PubMed ID: 10679655
[TBL] [Abstract][Full Text] [Related]
15. Maspin expression, subcellular localization and clinicopathological correlation in endometrial hyperplasia and endometrial adenocarcinoma.
Blandamura S; Alessandrini L; Saccardi C; Giacomelli L; Fabris A; Borghero A; Litta P
Histol Histopathol; 2014 Jun; 29(6):777-83. PubMed ID: 24346847
[TBL] [Abstract][Full Text] [Related]
16. Computerized image analysis of p53 and proliferating cell nuclear antigen expression in benign, hyperplastic, and malignant endometrium.
Elhafey AS; Papadimitriou JC; El-Hakim MS; El-Said AI; Ghannam BB; Silverberg SG
Arch Pathol Lab Med; 2001 Jul; 125(7):872-9. PubMed ID: 11419970
[TBL] [Abstract][Full Text] [Related]
17. Minimal uterine serous carcinoma: a clinicopathological study of 40 cases.
Hui P; Kelly M; O'Malley DM; Tavassoli F; Schwartz PE
Mod Pathol; 2005 Jan; 18(1):75-82. PubMed ID: 15389257
[TBL] [Abstract][Full Text] [Related]
18. Endometrial metaplasia as a source of atypical glandular cells in cervicovaginal smears.
Johnson TL; Kini SR
Diagn Cytopathol; 1996 Feb; 14(1):25-31. PubMed ID: 8834073
[TBL] [Abstract][Full Text] [Related]
19. Early detection of high-grade tubal serous carcinoma in women at low risk for hereditary breast and ovarian cancer syndrome by systematic examination of fallopian tubes incidentally removed during benign surgery.
Rabban JT; Garg K; Crawford B; Chen LM; Zaloudek CJ
Am J Surg Pathol; 2014 Jun; 38(6):729-42. PubMed ID: 24820399
[TBL] [Abstract][Full Text] [Related]
20. Significance of p53 expression in background endometrium in endometrial carcinoma.
Nguyen TT; Hachisuga T; Urabe R; Kurita T; Kagami S; Kawagoe T; Shimajiri S; Nabeshima K
Virchows Arch; 2015 Jun; 466(6):695-702. PubMed ID: 25788166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
